In 12 consecutive unselected patients admitted to a consultant maternity unit one single injection of subarachnoid morphine sulphate 15 mg abolished pain during the first stage of labour. Pain in the second stage was abolished in four patients and lessened in three. During the early puerperium, pain at the site of the episiotomy was much reduced. Side effects included itching of the face, nausea and vomiting, and frontal headache, but these were mild and simply treated. They were even less severe in the last four patients, in whom barbotage was not used in administering the morphine. The high rate of forceps delivery and caesarean section (three cases of each) was not thought to be associated with the use of intrathecal morphine.
Introduction
Intrathecal narcotics have been used in the management of various types of acute and chronic pain. ' We report here a pilot study in 12 unselected women to determine the effect of intrathecal morphine on pain during labour.
Patients and methods
The 12 patients were fit young women aged 19 to 30 years who were admitted consecutively to the consultant maternity unit at Bromsgrove General Hospital. They were taking no drugs and had no known allergies. Their medical histories and physical examination showed no contraindications to lumbar puncture or subarachnoid block. 2 The experimental nature of the study was described in detail and informed consent obtained.
With the patient comfortably in the left lateral position, a pillow between her legs, and her hips flexed, the skin of the back from the shoulders to the buttocks was prepared with an antiseptic aerosol spray (Betadine) and allowed to dry. After stringent aseptic precautions by the scrubbed, doubly-gloved, masked, and gowned operator (PVS) the skin between the spines of the third and fourth lumbar vertebrae, and, in one case, between L4 and L5, was infiltrated with 2 ml lignocaine.
After making a small (2-mm) incision in the anaesthetised skin, a 22-gauge disposable spinal needle was inserted into the subarachnoid space through a Sise introducer. The stylet was removed, a free flow of cerebrospinal fluid obtained, and the needle rotated through 360°to confirm that its bevel was entirely within the space.2 The stylet was replaced. The operator's second pair of gloves was removed by an assistant.
A 1 0-ml disposable plastic syringe containing specially formulated sterile morphine without preservative, bactericide, or antioxidant was attached to the spinal needle. (The 1 0-ml ampoule of morphine contained 10-0 mg/ml morphine sulphate in normal saline, specific gravity 1-0097, pH 5-6-5-7, sterilised by autoclaving. Morphine which contains a preservative, a bactericide, or an antioxidant must never be used intrathecally. Cerebrospinal fluid itself has a specific gravity of 1-003-1 009, pH 7-6.2)
Morphine 015 ml-that is, 15 mg-was then injected into the cerebrospinal fluid by barbotage.' The spinal needle was withdrawn and a sterile elastoplast dressing applied to the skin incision. Most patients then elected to lie supine. Induction of labour, if required, was performed 15-90 minutes later. In the last four cases barbotage was omitted.
Results and comments
Details of the mothers and their babies are given in the table. All mothers except two (cases 7 and 9) were normotensive and had been so throughout their pregnancies. No significant changes in blood pressure were seen before, during, or after intrathecal morphine. Pulse rate, respiratory depth (Wright's respirometer), respiratory frequency, and temperature were equally stable. There was no loss of tone in striated muscle and no apparent depression of uterine contractions. Blood loss throughout labour was in the normal range.
One patient (case 1) did not realise that she was in labour until the fetal head presented at the vulva, while another (case 2) did not realise it until the onset of the second stage. The remaining patients felt uterine contractions during the first stage, but they were painless as judged by patient and midwife. The pain of the second stage was abolished in one primigravida (case 4) and three multiparas (cases 6, 8, and 9 ) and appeared to be considerably diminished in three multiparas. There was no loss of the "pushing reflex," so allowing full maternal co-operation for the progress of the second stage.
Throughout the labours, which were conducted under oxytocin infusion, the fetal heart rate and uterine contractions were monitored continuously (Sonicaid fetal monitor, model FM2). There was no evidence of fetal distress in any patient except one, in whom the fetal heart rate fell to 80 beats/min, with late decelerations. The baby was delivered by immediate caesarean section.
After the six spontaneous deliveries Apgar scores at one minute were 9,7,6,8,9, and 9; at five minutes they were 10,8,8,10,10, and 10 (see table) . Apgar scores in babies delivered by forceps were 8,6, and 6 at one minute, and 10,8, and 10 at five minutes. One baby delivered by outlet forceps for delay in the second stage (case 12) was intubated and the lungs ventilated for one minute with oxygen; naloxone 0 04 mg was given. The babies delivered by caesarean section had Apgar scores of 8,9, and 9 at one minute and 10 in all three at five minutes.
Caesarean section was performed in three patients. 
Discussion
In this pilot study intrathecal morphine sulphate 1-5 mg in 0-15 ml normal saline abolished pain during the first stage of labour and abolished or lessened it during the second stage and early puerperium. These advantages were gained without the complications sometimes seen with the standard techniques of epidural analgesia.' Side effects were mild, simply treated and probably dose related. The facial itching might be a central effect of intrathecal morphine, mediated through internuncial neurones in the substantia gelatinosa of the spinal cord. The substantia gelatinosa is continuous in the upper cervical region of the cord with the nucleus of the trigeminal nerve.
Side effects can be reduced by omitting barbotage. In one subsequent patient not reported here they were reduced when only 10 mg morphine was used. Side effects might also be reduced by using opiates other than morphine: fentanyl, pethidine, buprenorphine, or, when they become available, the synthetic endorphins; by preoperative medication-for example, a long-acting antipruritic and antiemetic such as promethazine; or by treating severe persisting symptoms (especially nausea and vomiting) with intramuscular naloxone. Naloxone reverses some of the side effects of intrathecal morphine without seeming to antagonise the analgesic effects (J S Robinson, personal communication, 1980 The number of patients in this series was very small. There were three instrumental deliveries (incidence 25 0) and three caesarean sections (incidence 25%). We do not think that the apparently high rate of surgical interference bears any relation to the use of intrathecal morphine, but it is too early yet to be sure. Our next eight patients (not reported here) all delivered spontaneously, thus reducing the incidence of both forceps delivery and caesarean section to 15 " . In 1979 the incidence of forceps delivery among 1305 live births was 14-70' and the incidence of caesarean section 13 80,. The incidence of forceps delivery under epidural analgesia varies from 50%/ to 60%.
The use of intrathecal morphine in labour owes its origin to the basic work of Snyder4 and to reports on the use of intrathecal narcotics for managing various types of acute and chronic pain.' Epidural morphine has so far failed to relieve the pain of labour, perhaps because "the increased vascularity of the epidural space in pregnancy is responsible for rapid clearance of injected morphine so that effective concentrations of morphine in the cerebrospinal fluid and spinal cord are not reached."6
We consider that the use of intrathecal morphine to treat and prevent the pain of labour deserves a controlled study. If that study confirms our results the implications for the pregnant woman, for patients undergoing many types of surgery, and for the disciplines of obstetrics, neonatology, and especially anaesthetics, might well be profound. To assess the value of current advice we have studied the incidence of lupus syndrome in patients treated with hydrallazine in conventional doses and have also assessed the incidence of positive antinuclear factor titres in asymptomatic hypertensive patients. (11-25 months) . Presenting features included arthritis in five, rashes in two, and all showed marked weight loss before other symptoms. All had normal renal function. The ANF titre was raised in all six patients when they developed symptoms; DNA antibody, however, was often normal, only later becoming appreciably raised in three. When hydrallazine was discontinued clinical features resolved rapidly in four, one required non-steroid anti-inflammatory drugs and was symptom free at six months, and one has required steroids for over 12 months.
The two groups of asymptomatic hypertensive patients did not differ in age, sex ratio, dosage of 3-adrenergic blocker, or renal function. There were three positive ANF titres in those patients not taking hydrallazine, all of low titre (1/16), whereas in the hydrallazine-treated group 22 had positive ANF titres (seven at 1/16, 12 at 1/64, and three at 1/256). The frequency and distribution of positive ANF titres was significantly different between the two groups (p <0.005). In the group treated with hydrallazine positive ANF titres were more frequent in slow compared with rapid acetylators (20/43 v 2/18; p <0-025), but were not related to dose, duration of treatment, or renal function. Positive ANF titres were more common in women patients (p <0-05 for the groups combined).
Comment
Three per cent of patients developed a lupus-like syndrome while taking hydrallazine: all were slow acetylators and had not received more than 200 mg daily. The 
